首页> 外文期刊>African Journal of Pharmacy and Pharmacology >Design, formulation, optimization and evaluation of sustained release tablets of domperidone
【24h】

Design, formulation, optimization and evaluation of sustained release tablets of domperidone

机译:多潘立酮缓释片的设计,配制,优化和评价

获取原文
           

摘要

Domperidone is widely used in the management of gastric disorders, particularly gastro esophageal reflux disorder and peptic ulcer. But the short half-life of domperidone leads to poor compliance and adverse reactions; that is why domperidone in sustained release dosage form is needed to achieve better therapeutic effects and to improve patient? compliance. For this purpose sustained release tablets of domperidone were manufactured using different polymers, including hydroxylpropylmethylcellulose (HPMC) K100LV, hydroxylpropylcellulose (HPC) K100M and ethocel (EC-22). The prepared tablets were evaluated for their physical parameters, that is, weight variation was determined with the help of electronic balance, hardness by Monsanto tester, thickness by Vernier caliper and friability of the prepared tablets were determined with the help of Erweka friabilator and drug content was determined by UV/Visible spectrophotometer. The?in vitro?release studies were carried out for all the formulations of the model drug in a buffer solution of pH 6.8 and 0.1 N HCl solution. The results obtained were analyzed by different pharmacokinetic models, such as zero order, first order, Higuchi model, Hixson-Crowell cube root law and?Korsmeyer-Peppas model. All the materials used were available in the local market, so we could be able to minimize the per oral cast of the formulation and also improve the patient compliance by reducing the frequency of dosing, reduce relapse and improve therapeutic outcome.
机译:多潘立酮广泛用于治疗胃部疾病,特别是胃食管反流疾病和消化性溃疡。但是多潘立酮的半衰期短,导致依从性差和不良反应。这就是为什么需要缓释剂型多潘立酮以达到更好的治疗效果并改善患者的原因?合规性。为此,使用不同的聚合物(包括羟丙基甲基纤维素(HPMC)K100LV,羟丙基纤维素(HPC)K100M和ethocel(EC-22))制造了多潘立酮缓释片剂。对制备的片剂的物理参数进行评估,即,借助电子天平确定重量变化,通过孟山都测试仪确定硬度,通过游标卡尺测定厚度,并通过Erweka脆片测定仪确定制备的片剂的脆性和药物含量用紫外/可见分光光度计测定。在pH 6.8的缓冲溶液和0.1 N HCl的缓冲溶液中对模型药物的所有制剂进行了体外释放研究。所得结果通过不同的药代动力学模型进行了分析,例如零阶,一阶,Higuchi模型,Hixson-Crowell立方根定律和?Korsmeyer-Peppas模型。所有使用的材料都可以在当地市场上买到,因此我们可以通过减少给药频率,减少复发和改善治疗效果来最大程度地减少制剂的每次口服量,并改善患者的依从性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号